Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/11/2011
PIL ReQuip XL prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
Updated on 11/04/2011 and displayed until 14/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 08/11/2010 and displayed until 11/04/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 18/11/2008 and displayed until 08/11/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 28/05/2008 and displayed until 18/11/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ropinirole hydrochloride